Cover Image
市場調查報告書

加拿大的體外診斷 (IVD) 市場展望 2021年:臨床化學、遺傳基因檢驗、血液學、組織學 & 細胞學、免疫化學、感染疾病診斷、微生物培養

Canada In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

出版商 GlobalData 商品編碼 346088
出版日期 內容資訊 英文 259 Pages
訂單完成後即時交付
價格
Back to Top
加拿大的體外診斷 (IVD) 市場展望 2021年:臨床化學、遺傳基因檢驗、血液學、組織學 & 細胞學、免疫化學、感染疾病診斷、微生物培養 Canada In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
出版日期: 2015年08月14日 內容資訊: 英文 259 Pages
簡介

本報告提供加拿大的體外診斷 (IVD) 市場相關調查、主要的市場資料及各分類的市場規模、各市場分類的企業的佔有率和流通佔有率,及主要企業簡介,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 體外診斷 (IVD) 市場:加拿大

  • 收益:到目前為止的變化與預測
  • 綜合收益
  • 類別分配:各收益
  • 類別比較:各收益
  • 收益:到目前為止的轉變
  • 收益:預測
  • 企業佔有率:各收益

第4章 加拿大臨床化學市場

  • 綜合收益
  • 市場區隔分配
  • 收益:到目前為止的變遷
  • 收益:預測
  • 企業佔有率:各收益

第5章 加拿大的遺傳基因檢驗市場

第6章 加拿大的血液學市場

第7章 加拿大的組織學、細胞學市場

第8章 加拿大的免疫化學市場

第9章 加拿大的感染疾病診斷市場

第10章 加拿大的微生物培養市場

第11章 加拿大的主要企業概要:體外診斷市場

  • Siemens Healthcare
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • bioMerieux S.A.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Qiagen N.V.
  • Hologic, Inc.
  • Immucor, Inc.
  • Bio-Rad Laboratories, Inc.
  • Ortho-Clinical Diagnostics Inc.
  • Thermo Fisher Scientific Inc.
  • Sysmex Corporation
  • Alere Inc.
  • PerkinElmer, Inc.

第12章 體外診斷市場開發中產品

第13章 財務交易形勢

  • 收購
  • 資產交易
  • 新發行的債券
  • 股票上市
  • 聯盟
  • 創業融資

圖表

目錄
Product Code: GDMEMC0105DB

GlobalData's new report, "Canada In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the Canada In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for In Vitro Diagnostics market.
  • Global corporate-level profiles of key companies operating within the Canada In Vitro Diagnostics market.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. In Vitro Diagnostics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. In Vitro Diagnostics Market, Canada

  • 3.1. In Vitro Diagnostics Market, Canada, Revenue ($m), 2007-2021
  • 3.2. In Vitro Diagnostics Market, Canada, Revenue Mix ($m), 2014
  • 3.3. In Vitro Diagnostics Market, Canada, Category Contribution by Revenue ($m), 2014
  • 3.4. In Vitro Diagnostics Market, Canada, Category Comparison by Revenue ($m), 2007-2021
  • 3.5. In Vitro Diagnostics Market, Canada, Revenue ($m), 2007-2014
  • 3.6. In Vitro Diagnostics Market, Canada, Revenue ($m), 2014-2021
  • 3.7. In Vitro Diagnostics Market, Canada, Company Share by Revenue ($m), 2014

4. Clinical Chemistry Market, Canada

  • 4.1. Clinical Chemistry Market, Canada, Revenue Mix ($m), 2014
  • 4.2. Clinical Chemistry Market, Canada, Segment Contribution (%), 2014
  • 4.3. Clinical Chemistry Market, Canada, Revenue ($m), 2007-2014
  • 4.4. Clinical Chemistry Market, Canada, Revenue ($m), 2014-2021
  • 4.5. Clinical Chemistry Market, Canada, Distribution Share by Revenue ($m), 2013-2014
  • 4.6. Clinical Chemistry Market, Canada, Company Share by Revenue ($m), 2014

5. Genetic Testing Market, Canada

  • 5.1. Genetic Testing Market, Canada, Revenue Mix ($m), 2014
  • 5.2. Genetic Testing Market, Canada, Segment Contribution (%), 2014
  • 5.3. Genetic Testing Market, Canada, Revenue ($m), 2007-2014
  • 5.4. Genetic Testing Market, Canada, Revenue ($m), 2014-2021
  • 5.5. Genetic Testing Market, Canada, Distribution Share by Revenue ($m), 2013-2014
  • 5.6. Genetic Testing Market, Canada, Company Share by Revenue ($m), 2014

6. Haematology Market, Canada

  • 6.1. Haematology Market, Canada, Revenue Mix ($m), 2014
  • 6.2. Haematology Market, Canada, Segment Contribution (%), 2014
  • 6.3. Haematology Market, Canada, Revenue ($m), 2007-2014
  • 6.4. Haematology Market, Canada, Revenue ($m), 2014-2021
  • 6.5. Haematology Market, Canada, Distribution Share by Revenue ($m), 2013-2014
  • 6.6. Haematology Market, Canada, Company Share by Revenue ($m), 2014

7. Histology And Cytology Market, Canada

  • 7.1. Histology And Cytology Market, Canada, Revenue Mix ($m), 2014
  • 7.2. Histology And Cytology Market, Canada, Segment Contribution (%), 2014
  • 7.3. Histology And Cytology Market, Canada, Revenue ($m), 2007-2014
  • 7.4. Histology And Cytology Market, Canada, Revenue ($m), 2014-2021
  • 7.5. Histology And Cytology Market, Canada, Distribution Share by Revenue ($m), 2013-2014
  • 7.6. Histology And Cytology Market, Canada, Company Share by Revenue ($m), 2014

8. Immuno Chemistry Market, Canada

  • 8.1. Immuno Chemistry Market, Canada, Revenue Mix ($m), 2014
  • 8.2. Immuno Chemistry Market, Canada, Segment Contribution (%), 2014
  • 8.3. Immuno Chemistry Market, Canada, Revenue ($m), 2007-2014
  • 8.4. Immuno Chemistry Market, Canada, Revenue ($m), 2014-2021
  • 8.5. Immuno Chemistry Market, Canada, Distribution Share by Revenue ($m), 2013-2014
  • 8.6. Immuno Chemistry Market, Canada, Company Share by Revenue ($m), 2014

9. Infectious Diagnostics Market, Canada

  • 9.1. Infectious Diagnostics Market, Canada, Revenue Mix ($m), 2014
  • 9.2. Infectious Diagnostics Market, Canada, Segment Contribution (%), 2014
  • 9.3. Infectious Diagnostics Market, Canada, Revenue ($m), 2007-2014
  • 9.4. Infectious Diagnostics Market, Canada, Revenue ($m), 2014-2021
  • 9.5. Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), 2013-2014
  • 9.6. Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), 2014

10. Microbiology Culture Market, Canada

  • 10.1. Microbiology Culture Market, Canada, Revenue Mix ($m), 2014
  • 10.2. Microbiology Culture Market, Canada, Segment Contribution (%), 2014
  • 10.3. Microbiology Culture Market, Canada, Revenue ($m), 2007-2014
  • 10.4. Microbiology Culture Market, Canada, Revenue ($m), 2014-2021
  • 10.5. Microbiology Culture Market, Canada, Distribution Share by Revenue ($m), 2013-2014
  • 10.6. Microbiology Culture Market, Canada, Company Share by Revenue ($m), 2014

11. Overview of Key Companies in Canada, In Vitro Diagnostics Market

  • 11.1. Siemens Healthcare
  • 11.2. F. Hoffmann-La Roche Ltd.
  • 11.3. Abbott Laboratories
  • 11.4. bioMerieux S.A.
  • 11.5. Danaher Corporation
  • 11.6. Becton, Dickinson and Company
  • 11.7. Qiagen N.V.
  • 11.8. Hologic, Inc.
  • 11.9. Immucor, Inc.
  • 11.10. Bio-Rad Laboratories, Inc.
  • 11.11. Ortho-Clinical Diagnostics Inc.
  • 11.12. Thermo Fisher Scientific Inc.
  • 11.13. Sysmex Corporation
  • 11.14. Alere Inc.
  • 11.15. PerkinElmer, Inc.

12. In Vitro Diagnostics Market Pipeline Products

13. Financial Deals Landscape

  • 13.1. Acquisition
  • 13.2. Asset Transactions
  • 13.3. Debt Offerings
  • 13.4. Equity Offerings
  • 13.5. Partnerships
  • 13.6. Venture Financing

14. Appendix

  • 14.1. Research Methodology
  • 14.2. GlobalData Consulting
  • 14.3. Contact Us
  • 14.4. Disclaimer

List of Tables

  • Table 1: In Vitro Diagnostics Market, Canada, Revenue ($m), USD Constant, 2007-2021
  • Table 2: In Vitro Diagnostics Market, Canada, Category Contribution by Revenue ($m), 2014
  • Table 3: In Vitro Diagnostics Market, Canada, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 4: In Vitro Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: In Vitro Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 6: In Vitro Diagnostics Market, Canada, Company Share by Revenue ($m), USD Constant, 2014
  • Table 7: Clinical Chemistry Market, Canada, Segment Contribution (%), 2014
  • Table 8: Clinical Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 9: Clinical Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 10: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 11: Therapeutic Drug Monitoring Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 12: Urine Analysis Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 13: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 14: Therapeutic Drug Monitoring Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 15: Urine Analysis Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Clinical Chemistry Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 17: Clinical Chemistry Market, Canada, Company Share by Revenue ($m), USD Constant, 2014
  • Table 18: Genetic Testing Market, Canada, Segment Contribution (%), 2014
  • Table 19: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 20: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 21: Genetic Testing Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 22: Genetic Testing Market, Canada, Company Share by Revenue ($m), USD Constant, 2014
  • Table 23: Haematology Market, Canada, Segment Contribution (%), 2014
  • Table 24: Haematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 25: Haematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 26: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 27: Haematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 28: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 29: Haemostasis Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 30: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 31: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 32: Haematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 33: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 34: Haemostasis Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 35: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 36: Haematology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 37: Haematology Market, Canada, Company Share by Revenue ($m), USD Constant, 2014
  • Table 38: Histology And Cytology Market, Canada, Segment Contribution (%), 2014
  • Table 39: Histology And Cytology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 40: Histology And Cytology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 41: Histology And Cytology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 42: Histology And Cytology Market, Canada, Company Share by Revenue ($m), USD Constant, 2014
  • Table 43: Immuno Chemistry Market, Canada, Segment Contribution (%), 2014
  • Table 44: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 45: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 46: Anemia Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 47: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 48: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 49: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 50: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 51: Immunochemistry Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 52: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 53: Anemia Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 54: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 55: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 56: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 57: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 58: Immunochemistry Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 59: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 60: Immuno Chemistry Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 61: Immuno Chemistry Market, Canada, Company Share by Revenue ($m), USD Constant, 2014
  • Table 62: Infectious Diagnostics Market, Canada, Segment Contribution (%), 2014
  • Table 63: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 64: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 65: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 66: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 67: Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 68: Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), USD Constant, 2014
  • Table 69: Microbiology Culture Market, Canada, Segment Contribution (%), 2014
  • Table 70: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 71: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 72: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 73: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 74: Microbiology Culture Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 75: Microbiology Culture Market, Canada, Company Share by Revenue ($m), USD Constant, 2014
  • Table 76: In Vitro Diagnostics Market Pipeline Products
  • Table 77: OnSite Lab Invests USD1 Million in MedMira
  • Table 78: Canon Acquires Stake in Spartan Bioscience
  • Table 79: Empire Genomics Acquires ID Labs
  • Table 80: Sunrise to Acquire Event Cardio, Medical Device Company
  • Table 81: Valeant Pharma to Acquire Rights to IBSchek in US and Canada form Commonwealth Labs
  • Table 82: Xagenic Acquires Rights to Detection Technology from University of Toronto
  • Table 83: Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million
  • Table 84: SQI Diagnostics Completes Second and Final Tranche of Private Placement of Debentures for USD1.3 Million
  • Table 85: GeneNews to Raise up to USD2.4 Million in Private Placement of Units
  • Table 86: Miraculins Raises USD0.28 Million in Private Placement of Units
  • Table 87: SQI Diagnostics Raises USD2.2 Million In in First Tranche of Private Placement of Shares
  • Table 88: Miraculins Raise USD0.32 Million in Private Placement of Units
  • Table 89: Spectral Diagnostics Raises USD4.7 Million in Second Tranche of Private Placement of Shares
  • Table 90: GeneNews Raises USD1 Million upon Exercise of Warrants
  • Table 91: Miraculins Raises USD0.17 Million in Private Placement of Units
  • Table 92: M Pharma Raises USD1 Million in Private Placement of Units
  • Table 93: Miraculins Raises USD1.2 Million in Private Placement of Units
  • Table 94: Zecotek Photonics Raises USD2.5 Million in First Tranche of Private Placement of Units
  • Table 95: ChroMedX Raises USD0.56 Million in Private Placement of Units
  • Table 96: Med BioGene to Raise USD0.2 Million in Private Placement of Units
  • Table 97: Sigma-Aldrich Enters into Distribution Agreement with LGC
  • Table 98: OvaGene Oncology Enters into Agreement with Etta Healthcare
  • Table 99: InTouch Health Enters into Agreement with iSchemaView
  • Table 100: Royal Philips Enters into Co-Development Agreement with Profound Medical
  • Table 101: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment
  • Table 102: Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics
  • Table 103: GenomeDx Biosciences Enters into Agreement with Sidney Kimmel Cancer Center
  • Table 104: Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test
  • Table 105: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests
  • Table 106: PAML Enters into Co-Development Agreement with Axela
  • Table 107: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test
  • Table 108: IncellDx Enters into Licensing Agreement with Claremont BioSolutions
  • Table 109: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing
  • Table 110: AngioDynamics Enters into Licensing Agreement with EmboMedics
  • Table 111: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems
  • Table 112: BioMark Diagnostics Enters into Agreement with Metabolomics Innovation Centre
  • Table 113: Biocartis Enters into Licensing and Development Agreement with Microbiome
  • Table 114: CBScientific Enters into Distribution Agreement with UTest
  • Table 115: GE Healthcare Enters into Agreement with Sunnybrook Health Sciences
  • Table 116: GeneThera Enters into Co-Development Agreement with Hudson Robotics
  • Table 117: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D
  • Table 118: Genomic Vision Extends Agreement with Quest Diagnostics
  • Table 119: Caprion Enters into Licensing Agreement with Integrated Diagnostics for Xpresys Lung Test
  • Table 120: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ
  • Table 121: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software
  • Table 122: BioMerieux Enters into Licensing Agreement with Astute Medical
  • Table 123: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology
  • Table 124: NoemaLife Enters into Distribution Agreement with Horiba Medical
  • Table 125: Good Start Genetics Enters into Agreement with IviGen and iGenomix
  • Table 126: Clinical Genomics Enters into Licensing Agreement with CSIRO
  • Table 127: Hangzhou Joinstar Biomedical Enters into Co-Development Agreement with Response Biomedical
  • Table 128: MedMira Enters into Co-Development Agreement with Beacon Biomedical
  • Table 129: AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion
  • Table 130: BGI Forms Joint Venture with Vancouver Prostate Centre
  • Table 131: Ion Beam Applications Enters into Co-Development Agreement with Royal Philips
  • Table 132: Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies
  • Table 133: Ab Sciex Enters into Co-Development Agreement with Dalton Pharma
  • Table 134: Ohio State University and Nationwide Children's Hospital Enter into Licensing Agreement with NTvantage Diagnostics
  • Table 135: Hibergene Diagnostics Enters into Licensing Agreement with Eiken for LAMP
  • Table 136: Xagenic Raises USD11.78 Million in Series B Financing
  • Table 137: ChipCare Raises USD4 Million in Series A Venture Financing
  • Table 138: GenePOC Raises Funds through Venture Financing
  • Table 139: Fio Raises USD0.7 Million in Venture Financing
  • Table 140: Proteocyte Diagnostics Raises USD0.55 Million in Venture Financing

List of Figures

  • Figure 1: In Vitro Diagnostics Market, Canada, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: In Vitro Diagnostics Market, Canada, Revenue Mix ($m), 2014
  • Figure 3: In Vitro Diagnostics Market, Canada, Category Contribution (%), 2014
  • Figure 4: Vitro Diagnostics Market, Canada, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 5: In Vitro Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 6: In Vitro Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: In Vitro Diagnostics Market, Canada, Company Share (%) 2014
  • Figure 8: Clinical Chemistry Market, Canada, Revenue Mix ($m), 2014
  • Figure 9: Clinical Chemistry Market, Canada, Segment Contribution (%), 2014
  • Figure 10: Clinical Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 11: Clinical Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 12: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 13: Therapeutic Drug Monitoring Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 14: Urine Analysis Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 15: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 16: Therapeutic Drug Monitoring Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 17: Urine Analysis Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 18: Clinical Chemistry Market, Canada, Company Share (%) 2014
  • Figure 19: Genetic Testing Market, Canada, Revenue Mix ($m), 2014
  • Figure 20: Genetic Testing Market, Canada, Segment Contribution (%), 2014
  • Figure 21: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 22: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 23: Genetic Testing Market, Canada, Company Share (%) 2014
  • Figure 24: Haematology Market, Canada, Revenue Mix ($m), 2014
  • Figure 25: Haematology Market, Canada, Segment Contribution (%), 2014
  • Figure 26: Haematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 27: Haematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 28: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 29: Haematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 30: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 31: Haemostasis Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 32: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 33: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 34: Haematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 35: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 36: Haemostasis Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 37: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 38: Haematology Market, Canada, Company Share (%) 2014
  • Figure 39: Histology And Cytology Market, Canada, Revenue Mix ($m), 2014
  • Figure 40: Histology And Cytology Market, Canada, Segment Contribution (%), 2014
  • Figure 41: Histology And Cytology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 42: Histology And Cytology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 43: Histology And Cytology Market, Canada, Company Share (%) 2014
  • Figure 44: Immuno Chemistry Market, Canada, Revenue Mix ($m), 2014
  • Figure 45: Immuno Chemistry Market, Canada, Segment Contribution (%), 2014
  • Figure 46: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 47: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 48: Anemia Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 49: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 50: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 51: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 52: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 53: Immunochemistry Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 54: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 55: Anemia Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 56: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 57: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 58: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 59: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 60: Immunochemistry Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 61: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 62: Immuno Chemistry Market, Canada, Company Share (%) 2014
  • Figure 63: Infectious Diagnostics Market, Canada, Revenue Mix ($m), 2014
  • Figure 64: Infectious Diagnostics Market, Canada, Segment Contribution (%), 2014
  • Figure 65: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 66: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 67: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 68: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 69: Infectious Diagnostics Market, Canada, Company Share (%) 2014
  • Figure 70: Microbiology Culture Market, Canada, Revenue Mix ($m), 2014
  • Figure 71: Microbiology Culture Market, Canada, Segment Contribution (%), 2014
  • Figure 72: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 73: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 74: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 75: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 76: Microbiology Culture Market, Canada, Company Share (%) 2014
Back to Top